Here, we applied a high-throughput approach to investigate the ex vivo dynamics of peripheral blood melanoma-associated epitope-specific CD8+ T cell signatures in HLA-A*0201+ stage IV melanoma patients under ICB. The gene discussed is CD8A; the disease is melanoma.